Turning Point Therapeutics, Inc. TPTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

42/100

1/7 Pass

SharesGrow Intrinsic Value

There have been 50 recent insider transactions recorded for Turning Point Therapeutics, Inc. (TPTX), including 18 buys and 26 sells. Total insider buying was valued at $5.13M and total insider selling at $22.97M.

Notable insiders with recent activity include Machado Patrick, Gallagher Carol Giltner, Alles Mark J. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — TPTX

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2022-08-17	Machado Patrick	Director	Return of Shares	30,000	-	-	-
2022-08-17	Gallagher Carol Giltner	Director	Return of Shares	30,000	$39.99	$1.2M	-
2022-08-17	Alles Mark J	Director	Return of Shares	209	-	-	-
2022-08-17	Countouriotis Athena	President & CEO	Return of Shares	224,640	$37.68	$8.46M	-
2022-08-17	George Simeon	Director	Return of Shares	8,500	-	-	-
2022-08-17	Nicholson Garry A	Director	Return of Shares	8,500	$65.64	$557.94K	-
2022-08-17	Hirmand Mohammad	EVP and Chief Medical Officer	Return of Shares	41,284	$76.00	$3.14M	-
2022-08-17	Tombesi Paolo	EVP & Chief Financial Officer	Return of Shares	29,778	$76.00	$2.26M	-
2022-08-17	Bodem Barbara W.	Director	Return of Shares	14,995	$94.59	$1.42M	-
2022-08-17	Sun Brian	SVP & General Counsel	Return of Shares	45,000	$76.00	$3.42M	-
2022-08-17	Sabus Steve M	SVP & Chief Commercial Officer	Return of Shares	165,000	-	-	-
2022-07-27	Tombesi Paolo	EVP & Chief Financial Officer	Informative Sell	1,183	$74.94	$88.65K	28,700
2022-05-31	Sabus Steve M	Officer	Unknown	-	-	-	-
2022-05-31	Sabus Steve M	SVP & Chief Commercial Officer	RSU Award	165,000	-	-	165,000
2022-04-11	Sun Brian	Officer	Unknown	-	-	-	-
2022-04-11	Sun Brian	SVP & General Counsel	RSU Award	195,000	-	-	195,000
2022-02-09	North Annette	EVP & General Counsel	Informative Sell	669	$36.30	$24.28K	11,696
2022-02-09	Reich Siegfried	EVP & Chief Scientific Officer	Informative Sell	397	$36.30	$14.41K	3,448
2022-02-09	Countouriotis Athena	President & CEO	Informative Sell	2,971	$36.30	$107.85K	47,930
2022-02-09	Hirmand Mohammad	EVP & Chief Medical Officer	Informative Sell	669	$36.30	$24.28K	6,838
2022-02-09	Tombesi Paolo	EVP & Chief Financial Officer	RSU Award	16,283	-	-	29,883
2022-02-09	Partridge Andrew John	EVP & Chief Commercial Officer	Informative Sell	221	$36.30	$8.02K	22,078
2021-08-30	North Annette	EVP, General Counsel & Secty.	Informative Sell	10,000	$80.00	$800K	12,365
2021-07-26	Tombesi Paolo	Officer	Unknown	-	-	-	-
2021-07-26	Tombesi Paolo	EVP & Chief Financial Officer	RSU Award	13,600	-	-	13,600
2021-07-14	Partridge Andrew John	EVP & Chief Commercial Officer	Informative Sell	1,869	$74.90	$139.99K	21,767
2021-06-21	Alles Mark J	Director	Informative Buy	2,000	$81.34	$162.68K	2,000
2021-06-15	North Annette	EVP, General Counsel & Secty.	Informative Sell	6,634	$77.82	$516.26K	12,365
2021-06-02	Machado Patrick	Director	RSU Award	8,500	$65.64	$557.94K	8,500
2021-06-02	Gallagher Carol Giltner	Director	RSU Award	8,500	$65.64	$557.94K	8,500
2021-06-02	Alles Mark J	Director	RSU Award	209	$65.64	$13.72K	209
2021-06-02	George Simeon	Director	RSU Award	8,500	$65.64	$557.94K	8,500
2021-06-02	Nicholson Garry A	Director	RSU Award	8,500	$65.64	$557.94K	8,500
2021-05-24	Alles Mark J	Director	Unknown	-	-	-	-
2021-05-24	Alles Mark J	Director	RSU Award	17,000	$70.60	$1.2M	17,000
2021-05-14	Van Hoose Kyri K.	Officer	Unknown	-	-	-	-
2021-05-06	North Annette	EVP, General Counsel & Secty.	Option Exercise	5,882	$17.00	$99.99K	12,365
2021-03-31	Bodem Barbara W.	Director	Unknown	-	-	-	-
2021-03-31	Bodem Barbara W.	Director	RSU Award	14,995	$94.59	$1.42M	14,995
2021-03-23	Baker Brian Lee	SVP of Finance and Admin.	Option Exercise (Sell)	1,298	$3.20	$4.15K	-
2021-03-22	Baker Brian Lee	SVP of Finance and Admin.	RSU Award	1,625	-	-	4,116
2021-03-08	North Annette	EVP, General Counsel & Secty.	Informative Sell	700	$111.69	$78.18K	6,483
2021-03-04	Reich Siegfried	EVP & Chief Scientific Officer	Informative Sell	600	$111.46	$66.88K	3,845
2021-02-11	Countouriotis Athena	President & CEO	Informative Sell	3,052	$138.55	$422.85K	50,195
2021-02-10	Countouriotis Athena	President & CEO	Informative Sell	433	$138.19	$59.84K	50,195
2021-02-09	Countouriotis Athena	President & CEO	Informative Sell	1,104	$140.24	$154.82K	50,195
2021-02-08	North Annette	EVP, General Counsel & Secty.	RSU Award	6,483	-	-	6,483
2021-02-08	Reich Siegfried	EVP & Chief Scientific Officer	RSU Award	3,845	-	-	3,845
2021-02-08	Countouriotis Athena	President & CEO	RSU Award	22,617	-	-	50,195
2021-02-08	Hirmand Mohammad	EVP and Chief Medical Officer	RSU Award	6,483	-	-	6,767

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry